
1. trop med int health. 2018 dec;23(12):1374-1383. doi: 10.1111/tmi.13160. epub 2018
oct 23.

seroprevalence sarcocystosis local communities pangkor tioman
islands using recombinant surface antigens 3 (rsag3) sarcocystis falcatula.

tengku-idris tin(1), fong my(1), lau yl(1).

author information: 
(1)department parasitology, faculty medicine, university malaya, kuala
lumpur, malaysia.

objective: investigate seroprevalence sarcocystosis local
communities pangkor tioman islands, malaysia, using antigenic
recombinant surface antigens 2 3 sarcocystis falcatula (rsfsag2 and
rsfsag3) target proteins via western blot elisa assays.
methods: sfsag2 sfsag3 genes isolated s. falcatula expressed in
escherichia coli expression system. total 348 serum samples [volunteers from
both islands (n = 100), non-sarcocystis parasitic infections patients (n = 50)
and healthy donors (n = 100)] collected tested purified sfsags in
western blot elisa assays measure seroprevalence human
sarcocystosis.
results: none sera study reacted rsfsag2 western blot 
elisa. rsfsag3, relatively high prevalence sarcocystosis observed in
tioman island (75.5%) pangkor island (34%) western blot. elisa, the
different prevalence rate observed tioman island (43.8%) pangkor 
island (37%). prevalence rate parasitic infections (amoebiasis,
cysticercosis, filariasis, malaria, toxocariasis toxoplasmosis) 30% by
western blot 26% elisa. 8% (by western blot) 10% (by elisa) of
healthy donors showed reactivity towards rsfsag3.
conclusion: first study reporting seroprevalence sarcocystosis
in pangkor tioman islands, malaysia. combination western blot and
elisa suitable used serodiagnosis sarcocystosis. further
evaluations, sfsag3 potentially used confirm infection, asymptomatic
screening, surveillance epidemiological studies.

© 2018 john wiley & sons ltd.

doi: 10.1111/tmi.13160 
pmid: 30286271  [indexed medline]

